FR3115199A1 - NEW COSMETIC COMPOSITIONS - Google Patents

Abstract

New cosmetic compositions A composition is proposed. The composition is a water-in-oil emulsion comprising an aqueous phase and an oily phase. The aqueous phase includes water, one or more humectants, one or more preservatives, one or more preservative enhancers, one or more stabilizers and/or one or more pH adjusters. The aqueous phase comprises one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers. Methods for preparing the composition and methods for improving the appearance of the skin are also provided. Figure for the abstract: none

Description

NEW COSMETIC COMPOSITIONS

FIELD OF THE INVENTION

The invention relates to a novel cosmetic composition for improving the appearance of the skin by reducing the appearance of fine lines and wrinkles and imperfections in the appearance and texture of the skin in a texture pleasant to consumers and for improving the radiance of the skin on application.

BACKGROUND OF THE INVENTION

Previous clinical studies have shown glycerin to have anti-aging benefits.

The anti-aging benefit of retinol has also been well-studied and is often used as a benchmark for anti-aging. In particular, 0.15% retinol is often considered to provide the best results in terms of anti-aging benefits, but implications for skin irritation are often seen.

In addition, make-up products containing aesthetic modifiers often offer consumers a pleasant texture that improves the radiance of the skin on application.

Disclosed is a stable and effective water-in-oil emulsion system with 10% glycerin, polyacid esters and/or ethyl acetal levulinate derivatives, and aesthetic modifiers, including functional fillers and effect pigments for improving the appearance of the skin by reducing the appearance of fine lines and wrinkles and imperfections in the appearance and texture of the skin in a consumer-friendly texture and for improving the radiance of the skin skin on application.

The inventors have unexpectedly discovered that the combination of polyacid esters and/or ethyl acetal levulinate derivatives with glycerin and aesthetic modifiers provide surprisingly effective anti-aging benefits and an instant optical effect to reduce the appearance of fine lines and wrinkles and blemishes on the skin.

A composition is proposed. The composition comprises an aqueous phase and an oily phase. The aqueous phase includes water, one or more humectants, and one or more preservatives, preservative enhancers and/or stabilizers. The oily phase comprises one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers. The one or more solvents are selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these. The composition is a water-in-oil emulsion.

The one or more solvents may be selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these. The one or more solvents can be diisopropyl adipate and diisopropyl sebacate. The one or more solvents can be diisopropyl adipate and ethyl PG-acetal levulinate. The one or more solvents may be diisopropyl adipate and ethyl glycerin acetal levulinate. The one or more solvents can be diisopropyl adipate and triethyl citrate.

The oily phase further comprises one or more aesthetic modifiers, which include both at least one functional filler and at least one effect pigment.

Functional fillers include, but are not limited to, cross-linked polymer of methyl methylacrylate, boron nitrile, bismuth oxychloride, polymethylsilsesquioxane. They provide an optical blurring effect to minimize the appearance of fine lines and wrinkles and facial blemishes, and to create a more youthful appearance.

Effect pigments are conventionally mineral or synthetic substances with a treated or untreated surface, such as titanium dioxide, mica, synthetic fluorphlogopite or borosilicates. These effect pigments can further comprise a monolayer or multilayer structure by coating the surface with titanium dioxide or additional iron oxides, or other coloring materials. The effect pigments in said composition can give a clearer and healthier complexion to their users and further improve their overall appearance.

Appearance modifiers may be incorporated into the oil phase in the range of 3-12% by weight or 4-10% by weight, based on the total weight of the composition.

The oily phase may additionally comprise a preservative.

A process for preparing the composition of the invention is also provided. The method of preparation includes providing an aqueous phase comprising components: water, one or more humectants, and one or more preservatives, preservative enhancers and/or stabilizers; providing an oil phase comprising one or more solvents, one or more emulsifiers, one or more emollients, and one or more aesthetic modifiers; and contacting the water phase components with the oil phase components to form a water-in-oil emulsion. The one or more solvents may be selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these. Due to this, the composition is prepared.

A method of improving the appearance of skin in a subject is further provided. The method comprises applying to the skin an effective amount of the composition of the present invention. Improving the appearance of the skin may include treating or reducing the appearance of wrinkles, fine lines and imperfections in the appearance and texture of the skin.

Figure 1 shows the result of the tolerability study in terms of dryness.

Figure 2 shows the result of the tolerability study in terms of desquamation.

Figure 3 shows the result of the tolerability study in terms of erythema.

DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to cosmetic compositions comprising one or more solvents, which may be diacid esters and/or ethyl acetal levulinate derivatives, to solubilize the active compound, and methods of using the compositions to treat, protect and /or improve the conditions and/or the aesthetic appearance of the skin. This invention has been made on the basis of the astonishing discovery of the inventors that stable water-in-oil emulsions comprising an oily phase with polyacid esters and/or derivatives of ethyl acetal levulinate, 10% glycerin, and aesthetic modifiers could provide desirable anti-aging benefits, and an instant optical effect to reduce the appearance of wrinkles, fine lines, and blemishes on the skin.

Unless otherwise stated, a figure in % by weight for an ingredient of a composition relates to the total weight of the composition.

The present invention provides a composition. The composition comprises an aqueous phase and an oil phase, and is a water-in-oil emulsion. The composition is stable.

The term "stable" as used here refers to a physical or chemical property of a cosmetic composition that does not change significantly over time. For example, a cosmetic composition may be considered stable if no amount of significant change (e.g., less than about 10, 5, 1, 0.5, or 0.1% by weight) is observed in terms of precipitation , color, pH, viscosity profile or SEM images for the cosmetic composition after storage for, for example, at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 , 11, 12, 15, 18, 21 or 24 weeks, at a temperature of about 4 to 45°C, for example, at room temperature (25°C) or at 45°C, and/or at atmospheric pressure (760 mm Hg, i.e. 105 Pa). A composition that remains clear, with no visible precipitation, for at least about 8, 12, 16, 20 or 24 hours can be considered stable. A composition which remains clear, with no visible precipitation, for at least about 4 to 8 weeks at about 25°C or 45°C can be considered stable.

The oily phase further comprises one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers.

The solvent can be a polyacid ester or an ethyl acetal levulinate derivative. The polyacid ester can be diisopropyl adipate, acetyl tributyl citrate, triethyl citrate, dicaprylyl maleate, triisocetyl citrate, diisocetyl dodecanedioate, trioctyldodecyl citrate, diisostearyl malate, tridecyl trimellitate, tri-C14-15 alkyl citrate, di-C12-13 alkyl malate, dimyristyl tartrate, di-C12-13 alkyl tratrate, diisopropyl sebacate, tributyl citrate, diethylhexyl maleate, or di-PPG-3 myristyl ether adipate. The polyacid ester is preferably a diacid ester such as diisopropyl adipate or diisopropyl sebacate. The derivative of ethyl acetal levulinate can be ethyl PG-acetal levulinate or ethyl glycerine acetal levulinate.

The one or more solvents may be selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these.

The one or more solvents may consist of two solvents. For example, the one or more solvents can be diisopropyl adipate and diisopropyl sebacate; diisopropyl adipate and ethyl PG-acetal levulinate; diisopropyl adipate and ethyl glycerin acetal levulinate; or diisopropyl adipate and triethyl citrate.

The emulsifier may be selected from the group consisting of lauryl PEG-9 polydimethylsiloxyethyl dimethicone; lauryl polyglyceryl-3 polydimethylsiloxyethyl dimethicone; dimethicone/PEG-10/15 cross-linked polymer; dimethicone/polyglycerin-3 cross-linked polymer; PEG-15/lauryl dimethicone cross-linked polymer; PEG-15/lauryl polydimethylsiloxyethyl dimethicone cross-linked polymer; lauryl dimethicone/polyglycerin-3 cross-linked polymer; polyglycerin-3/lauryl polydimethylsiloxyethyl dimethicone cross-linked polymer; cetyl PEG/PPG-10/1 dimethicone; lauryl PEG/PPG-18/18 methicone; PEG/PPG-18/18 dimethicone; and a combination thereof. The composition may include about 1-10% by weight, 3-9% by weight, or 4-8% by weight of the emulsifier, based on the total weight of the composition.

The emollient may be selected from the group consisting of dimethicone/vinyl dimethicone cross-linked polymer; dimethicone/phenyl vinyl dimethicone cross-linked polymer; vinyl dimethicone/lauryl dimethicone cross-linked polymer; and a combination thereof. The composition may include about 5-25% by weight, 10-20% by weight, 1-14% by weight, or 15-20% by weight of the emollient, based on the total weight of the composition.

The oil phase may further comprise one or more cosmetic modifiers at, for example, 3-12% by weight or 4-10% by weight, based on the total weight of the composition. The resulting composition can provide instant improved skin appearance.

Esthetic modifiers include both at least one functional filler and at least one effect pigment.

Functional fillers include, but are not limited to, cross-linked polymer of methyl methacrylate, boron nitrile, bismuth oxychloride, polymethylsilsesquioxane. They offer an optical blur effect to minimize the appearance of wrinkles, fine lines and facial imperfections, and to create a more youthful appearance.

Effect pigments are conventionally mineral or synthetic substances with a treated or untreated surface, such as titanium dioxide, mica, synthetic fluorphlogopite or borosilicates. These effect pigments can further comprise a monolayer or multilayer structure by coating the substance with titanium dioxide or additional iron oxides, or other coloring materials. The effect pigments in said composition can give a clearer and healthier complexion to their users and further improve their overall appearance.

The oily phase may further comprise a preservative at, for example, 0.1 to 2% by weight or 0.12 to 0.18% by weight, based on the total weight of the composition. The preservative can be selected from the group consisting of p -anisic acid, phenoxyethanol, chlorphenesin, and a combination thereof.

The aqueous phase comprises water, one or more humectants, one or more preservatives, one or more preservative enhancers, one or more stabilizers and/or one or more pH adjusters.

The composition may contain from about 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 30-80%, 30-70%, 30-60 %, 30-50%, 30-40%, 35-65%, or 40-60% water.

The humectant can be glycerin, propanediol, propylene glycol, butylene glycol, dipropylene glycol or a combination thereof. The composition may include about 5-15 wt%, 8-12 wt%, or 9-11 wt% of the humectant, based on the total weight of the composition.

The preservative in the aqueous phase can be selected from the group consisting of phenoxyethanol, chlorphenesin, p -anisic acid, and a combination thereof. The composition may include about 0.2 to 0.70% by weight, 0.25 to 0.40% by weight, or 0.30 to 0.35% by weight of the preservative, based on the total weight of the composition.

The preservative enhancer may be disodium EDTA. The composition may include about 0.05 to 0.20 wt%, 0.75 to 0.15 wt%, or 0.09 to 0.11 wt% of the preservative enhancer, based on total weight of composition.

The stabilizer can be selected from the group consisting of sodium citrate, sodium chloride, and a combination thereof. The composition can include about 0.1 to 1.5 wt%, 0.5 to 1.0 wt%, or 0.6 to 0.8 wt% of the stabilizer, based on the total weight of the composition.

The pH adjuster can be citric acid. The composition may include about 0.01 to 0.05% by weight or 0.02 to 0.04% by weight of the pH adjuster, based on the total weight of the composition.

The composition of the present invention may be in the form of a liquid dispersion, a gel, a cream, a lotion, a mousse, or a spray. The composition can be in the form of a liquid emulsion such as a liquid lotion, a gel lotion or a liquid cream, or a creamy emulsion such as a thick cream or a gel cream, or a foam . The liquid emulsion form may have a more fluid consistency than the creamy emulsion form.

For each composition, a process for preparing the composition is provided. The method of preparation includes providing an aqueous phase, an oil phase, and contacting the components of the aqueous phase with the components of the oil phase to form a water-in-oil emulsion. The components of the aqueous phase include water, one or more humectants, one or more preservatives, one or more preservative enhancers, one or more stabilizers and/or one or more pH adjusters. The oil phase components include one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers.

A method of improving the appearance of skin in a subject is also provided. The method comprises applying to the skin an effective amount of the composition of the present invention. The composition is a water-in-oil emulsion comprising an aqueous phase and an oily phase. The oily phase comprises one or more solvents, one or more emulsifiers, one or more emollients, and/or one or more aesthetic modifiers. Improving the appearance of the skin may include treating or reducing the appearance of wrinkles, fine lines, and imperfections in the appearance and texture of the skin, for example, spots, dryness , roughness, dullness, age spots, loose and/or puffy skin.

The subject may be a consumer in need of a better appearance of her skin. The consumer can be a human being. The subject may exhibit wrinkles, fine lines, and/or imperfections in the appearance or texture of the skin. The improved appearance of the skin may be the reduction of wrinkles, fine lines, and/or imperfections in the appearance or texture of the skin. The composition can be applied to the facial skin, for example, around the eyes, mouth, and/or on the neck, of the subject.

The term "about" as used herein when referring to a measurable value such as quantity, percentage, and the like, is intended to encompass variations of + 20% or + 10%, preferably + 5%, more preferably + 1%, and even more preferably + 0.1% from the indicated value, as these variations are appropriate.

Example 1. Emulsion Compositions

Water-in-oil (silicone) emulsion compositions have been prepared by combining different solvents and then incorporating the mixture of solvents into an oil phase of an emulsion. Table 1 shows the ingredients of emulsion compositions, Invention Examples 1 to 4. Phase A was an oil phase, wherein phase A1 comprised one or more emulsifiers, one or more solvents; phase A2 included one or more oil-dispersible emollients to improve the feel of the composition; and phase A3 optionally included one or more aesthetic modifiers, for example, a combination of effect pigments and/or functional fillers, for instantly improved skin appearance. Phase B was an aqueous phase comprising water, a humectant, one or more preservatives, preservative enhancers and/or stabilizers.

In carrying out each of Invention Examples 1 through 4, the following procedure was followed. Phase B (water phase) ingredients were mixed together in an auxiliary kettle at room temperature or higher. Phase A (oil phase) ingredients were mixed together in a main kettle at room temperature or higher. The mixture of Phase B ingredients (water phase) was slowly added into the mixture of Phase A ingredients (oil phase), while mixing. As the viscosity of the mixture increased, the mixing speed in the main kettle was increased to about 1200 rpm. After Phase B (water phase) was mixed into Phase A (oil phase), a water-in-oil (silicone) emulsion was formed.

The stability of Inventive Examples 1-4 was evaluated in an 8-week accelerated stability test. The emulsion compositions were stable.

Invented we Invented we Invented we Invented we Phase INCI name Example 1 Example 2 Example 3 Example 4 A1 LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE 1 1 1 2 A1 DIISOPROPYL ADIPATE 10 10 10 10 A1 ETHYL PG-ACETAL LEVULINATE 12.5 A1 ETHYL GLYCERINE ACETAL LEVULINATE 7 A1 DIISOPROPYL SEBACATE 7 A1 ISOPROPYL LAUROYL SARCOSINATE 3 A1 TRIETHYL CITRATE 4 A1 p-ANISIC ACID 0.15 0.15 0.15 0.15 A2 DIMETHICONE (and) CROSS LINKED POLYMER DIMETHICONE/PEG-10/15 7 7 7 5 A2 DIMETHICONE (and) CROSS LINKED POLYMER DIMETHICONE/VINYL DIMETHICONE 20 15 20 10 A3 TITANIUM DIOXIDE (and) DIMETHICONE 0.3 0.3 0.3 0.3 A3 CROSS LINKED POLYMER OF METHYL METHACRYLATE 2 2 2 2 A3 BORON NITRIDE 1 1 1 1 A3 BISMUTH OXYCHLORIDE 0.4 0.4 0.4 0.4 A3 POLYMETHYLSILSESQUIOXANE 2 A3 MICA (and) TITANIUM DIOXIDE 0.82 0.82 0.82 0.82 A3 IRON OXIDES (and) MICA 0.08 0.08 0.08 0.08 A3 MICA (and) TITANIUM DIOXIDE (and) IRON OXIDES 0.15 0.15 0.15 0.15 B Water (SQ) 35.99 37.49 37.99 48.99 B GLYCERIN 10 10 10 10 B PHENOXYETHANOL 0.5 0.5 0.5 0.5 B CHLORPHENESIN 0.27 0.27 0.27 0.27 B HYDROXYACETOPHENONE 0.5 0.5 0.5 0.5 B DISODIUM EDTA 0.1 0.1 0.1 0.1 B Sodium Citrate 0.2 0.2 0.2 0.2 B Sodium Chloride 0.5 0.5 0.5 0.5 B CITRIC ACID 0.04 0.04 0.04 0.04 Total (%): 100 100 100 100

Table 1. Emulsion compositions

Example 2. Comparisons to a reference product containing 0.15% retinol

Comparative Example 1, which was a reference product, was used in the comparative tests. It has the following list of ingredients:

Water, Pentaerythrityl Tetraethylhexanoate, Dimethicone, Glycerin, PPG-15 Stearyl Ether, Cetearyl Alcohol, Stearyl Alcohol, Butylene Glycol, Ceteareth-20, Isohexadecane, Trisiloxane, Dimethicone Cross-Linked Polymer, Phenoxyethanol, Caprylyl Glycol, Acryloyldimethyltaurate Copolymer 'Ammonium/vp, Polyacrylamide, Polyethylene, Chlorphenesin, C13-14 Isoparaffin, Ptfe, Hydrolyzed Myrtus Communis Leaf Extract, BHT, Sodium Hyaluronate, Edta Disodium, Laureth-7, Ascorbic Acid, Polysorbate 20, Retinol, and Hydroxide Sodium.

Clinical studies have been performed using a monadic design to evaluate the anti-aging efficacy of test products after 6 months of use. Two test products (Invention Example 1 and the reference product) were provided to Caucasian women aged 40 to 65 with mild to moderate wrinkles (grades 2 to 4 on the 0 to 6 of the L'Oréal Atlas). The panelists were asked to apply the test product to the entire face twice a day. For the reference product, a preparation step was carried out for the purpose of adaptation, ie only 2 applications in Week 1 and gradual increase to two applications per day from Week 4. A total of 121 subjects completed the study.

Self-Assessment Questionnaire:

Many immediate effects were assessed by the Self-Assessment Questionnaire comparing Invention Example 1 to the reference product. Table 2 illustrates the result of the evaluation.

As shown in Table 2, on Day 0, Inventive Example 1 performed better than the reference product in immediately improving skin tone and in improving the healthy appearance of skin over time. day 0, while no significant difference was perceived by the test subjects in the other parameters.

On Day 168, no significant difference was perceived by the test subjects in the other parameters. Overall, no difference in perception of the test products was observed by the subjects after 6 months of use.

Day 0
(Immediately after the first application of the test product) Comparison between test products 1 Crow's feet wrinkles seem less visible NS 2 Wrinkles under the eyes appear less visible NS 3 Bags under the eyes appear reduced/softened NS 4 Dark circles under the eyes appear faded/softened NS 5 The skin is radiant/glowing Example of Invention 1 > Comparative Example 1 (SS) 6 Skin looks brighter NS 7 Skin tone looks even NS 8 Blackheads appear faded/softened NS 9 The skin is soft NS 10 Skin feels soft NS 11 The skin is less oily NS 12 Skin looks hydrated NS 13 Skin looks rejuvenated/refreshed NS 14 Skin looks healthy Example of Invention 1 > Comparative Example 1 (SS) 15 I am happy with the appearance of my skin NS

Day 168
(Evaluation on a clean face) Comparison between test products 1 Crow's feet wrinkles are not visible NS 2 Wrinkles under the eyes are not visible NS 3 Bags under the eyes are not visible NS 4 Dark circles under the eyes are not visible NS 5 The skin is radiant/glowing NS 6 Skin looks brighter NS 7 Skin tone looks even NS 8 Blackheads appear faded/softened NS 9 The skin is soft NS 10 Skin feels soft NS 11 The skin is less oily NS 12 Skin looks hydrated NS 13 Skin looks rejuvenated/refreshed NS 14 Skin looks healthy NS 15 I am happy with the appearance of my skin NS

Table 2. Self-Assessment Questionnaire

Subjective tolerability

Figures 1 to 3 show the results of the tolerability study in terms of dryness, desquamation and erythema, respectively. Overall, Invention Example 1 was better tolerated than Comparative Example 1, with less dryness, less scaling and less erythema.

Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details indicated. On the contrary, various modifications may be made to the details within the scope and range of equivalents of the claims without departing from the invention.

Clinical efficacy

The evaluation was performed by expert dermatologists assessing (1) crow's feet, (2) forehead wrinkle, (3) under eye wrinkle, (4) skin tone evenness, (5) the softness of the skin to the touch, (6) the visual smoothness of the skin.

Both products tested gave similar results and showed improvement from baseline at Day 56. Both treatments improved clinical efficacy endpoints at 6 months (no difference, p>0.1).

No difference in results between the products tested at 6 months for crow's feet, forehead wrinkles and uniformity of skin tone.

Bioinstrumentation

Both treatments significantly improved skin hydration compared to baseline (SS). [SS = statistically significant]. Invention Example 1 improved the P.I.E. compared to baseline at 6 months (SS).

Both treatments reduced mean wrinkle depth from baseline at 6 months (SS).

Instrumental evaluation

1. Skin hydration: Both products significantly improved skin hydration from baseline from Day 28.

2. Skin Barrier Function (P.I.E.): P.I.E. decreased significantly from baseline on Day 28 for Invention Example 1, while Comparative Example 1 did not show improvement until Day 140.

3. Analysis of Primos 3D images of crow's feet wrinkles: wrinkle depth, wrinkle area and number of wrinkles: no significant difference between treatments at each time point.

Claims (9)

Cosmetic composition, comprising:
(a) an aqueous phase comprising:
(i) water,
(ii) one or more humectants, and
(iii) one or more preservatives, preservative enhancers and/or stabilizers; And
(b) an oily phase comprising:
(i) one or more solvents selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these,
(ii) one or more emulsifiers, and
(iii) one or more emollients; And
(iv) one or more aesthetic modifiers;
wherein the composition is a water-in-oil emulsion. A composition according to claim 1, wherein the one or more solvents are selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, citrate triethyl and a combination thereof. A composition according to claim 1, wherein the one or more aesthetic modifiers comprise one or more functional fillers and one or more effect pigments. Composition according to Claim 3, in which the functional fillers are selected from the group consisting of cross-linked polymer of methyl methylacrylate, boron nitrile, bismuth oxychloride, and polymethylsilsesquioxane. Composition according to Claim 3, in which the effect pigments are selected from surface-treated or untreated mineral or synthetic substances, such as titanium dioxide, mica, synthetic fluorophlogopite and borosilicates. A composition according to claim 5, wherein the effect pigments comprise a monolayer or multilayer structure by coating their surface with titanium dioxide or additional iron oxides, or other coloring materials. Process for the preparation of a cosmetic composition, comprising the steps of:
(a) providing an aqueous phase comprising:
(i) water,
(ii) one or more humectants, and
(iii) one or more preservatives, preservative enhancers and/or stabilizers;
(b) providing an oily phase comprising:
(v) one or more solvents selected from the group consisting of diisopropyl adipate, diisopropyl sebacate, ethyl PG-acetal levulinate, ethyl glycerine acetal levulinate, triethyl citrate and a combination of these,
(vi) one or more emulsifiers, and
(vii) one or more emollients; And
(viii) one or more aesthetic modifiers;
(c) contacting the aqueous phase components with the oil phase components to form a water-in-oil emulsion. A method of improving the appearance of the skin in a subject, comprising applying to the skin an effective amount of the composition according to claim 1. A method according to claim 8, wherein improving the appearance of the skin comprises reducing the appearance of wrinkles, fine lines, blemishes and imperfections in the appearance and texture of the skin.